PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26304989-4	2015	Interestingly, although treated CD40 KO mice remained healed, developed long-term immunity, and were resistant to secondary L. major challenge, treated CD40L KO reactivated their lesion after cessation of rIL-12 treatment.	ril-12	205-211	CD40 ligand	Mus musculus	152-157	
16920960-4	2006	This defect is probably due to impaired CD40-dependent IL-12 production in vivo, because administration of anti-CD40 Ab, or rIL-12, restored IFN-gamma production by sdLN cells from CD154-/- mice.	ril-12	124-130	CD40 ligand	Mus musculus	181-186	
17485453-7	2007	However, the treatment of CD154(-/-) mice with rIL-12 did not restore protection.	ril-12	47-53	CD40 ligand	Mus musculus	26-31	
26304989-6	2015	We show that IL-12 production by dendritic cells and macrophages via CD40L-macrophage Ag 1 (Mac-1) interaction is responsible for the sustained resistance in CD40 KO mice after cessation of rIL-12 treatment.	ril-12	190-196	CD40 ligand	Mus musculus	69-74